Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04301765 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

Study acronym: TEMEC
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Recruiting → Active, Not Recruiting
    • Primary and study completion dates: Nov 1, 2026 to Nov 2026
    • Site details revised at 3 of 3 sites
    v18
  2. Primary and study completion dates: Jan 31, 2026 to Nov 1, 2026
    • Site contacts updated at 1 of 3 sites
    v17
  3. Primary and study completion dates: Jan 1, 2026 to Jan 31, 2026
    • Site contacts updated at 2 of 3 sites
    v16
  4. Site contacts updated at 2 of 3 sitesv15
  5. Eligibility criteria shortened, about 41 words
    • Study description revised
    • Site contacts updated at 1 of 3 sites
    v14
Show 12 earlier versionsHide 12 earlier versions
  1. Site contacts updated at 1 of 3 sitesv13
  2. Primary completion date: Jun 30, 2026 to Jan 1, 2026
    • Study completion date: Dec 31, 2026 to Jan 1, 2026
    v12
  3. Primary completion date: Jun 30, 2025 to Jun 30, 2026
    • Study completion date: Dec 31, 2025 to Dec 31, 2026
    v11
  4. Study sites: 2 to 3
    • Eligibility criteria revised
    v10
  5. Study sites: 3 to 2
    • Primary completion date: Jun 2025 to Jun 30, 2025
    • Study completion date: Dec 2025 to Dec 31, 2025
    v9
  6. Site details revised at 2 of 3 sitesv8
  7. Eligibility criteria expanded, about 26 words
    • Study description expanded, about 1 word
    v7
  8. Re-verified, no change to tracked fieldsv6
  9. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 2021 to Jan 12, 2021
    • Site details revised at 3 of 3 sites
    v5
  10. Start date: Nov 2020 to Feb 2021v4
  11. Start date: Jun 2020 to Nov 2020v3
  12. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a large randomized, double-blind, placebo-controlled trial to determine the efficacy of testosterone replacement on cancer-related fatigue in older men with solid or hematologic (blood) cancer who report fatigue and have low testosterone levels.
Trial Details
NCT Number NCT04301765
Lead Sponsor Seattle Institute for Biomedical and Clinical Research
Conditions
(from sponsor)		 Hypogonadism, Male, Cancer, Fatigue
Related terms Eunuchism, Fatigue, Hypogonadism, Neoplasms
Enrollment 230 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov